These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38340655)

  • 1. Hyaluronic acid-modified mesoporous silica nanoprobes for target identification of atherosclerosis.
    Ma R; Hao L; Cheng J; He J; Yin Q; Li Z; Qi G; Zheng X; Wang D; Zhang T; Cong H; Li Z; Hu H; Wang Y
    Biochem Biophys Res Commun; 2024 Apr; 702():149627. PubMed ID: 38340655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticles functionalized with hyaluronic acid. Effect of the biopolymer chain length on cell internalization.
    Nairi V; Magnolia S; Piludu M; Nieddu M; Caria CA; Sogos V; Vallet-Regì M; Monduzzi M; Salis A
    Colloids Surf B Biointerfaces; 2018 Aug; 168():50-59. PubMed ID: 29456044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells.
    Gary-Bobo M; Brevet D; Benkirane-Jessel N; Raehm L; Maillard P; Garcia M; Durand JO
    Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):256-60. PubMed ID: 22959805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis.
    Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y
    Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery.
    Naz S; Wang M; Han Y; Hu B; Teng L; Zhou J; Zhang H; Chen J
    Int J Nanomedicine; 2019; 14():2533-2542. PubMed ID: 31114189
    [No Abstract]   [Full Text] [Related]  

  • 8. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-guest fabrication of dual-responsive hyaluronic acid/mesoporous silica nanoparticle based drug delivery system for targeted cancer therapy.
    Lu J; Luo B; Chen Z; Yuan Y; Kuang Y; Wan L; Yao L; Chen X; Jiang B; Liu J; Li C
    Int J Biol Macromol; 2020 Mar; 146():363-373. PubMed ID: 31911174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.
    Wang D; Huang J; Wang X; Yu Y; Zhang H; Chen Y; Liu J; Sun Z; Zou H; Sun D; Zhou G; Zhang G; Lu Y; Zhong Y
    Biomaterials; 2013 Oct; 34(31):7662-73. PubMed ID: 23859657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets.
    Zhang W; Lv Z; Zhang Y; Gopinath SCB; Yuan Y; Huang D; Miao L
    Oxid Med Cell Longev; 2022; 2022():6006601. PubMed ID: 36211824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan-based nano-formulation with mesoporous silica enhances the anticancer efficacy of phloroglucinol against gastrointestinal cancers.
    Shanmugam L; Venkatasubbu GD; Jayaraman M
    Int J Biol Macromol; 2024 Apr; 265(Pt 1):130856. PubMed ID: 38490393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid targeted and pH-responsive multifunctional nanoparticles for chemo-photothermal synergistic therapy of atherosclerosis.
    Liu S; Zhao Y; Shen M; Hao Y; Wu X; Yao Y; Li Y; Yang Q
    J Mater Chem B; 2022 Jan; 10(4):562-570. PubMed ID: 34982089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T
    Li J; You J; Wu C; Dai Y; Shi M; Dong L; Xu K
    Int J Nanomedicine; 2018; 13():4607-4625. PubMed ID: 30127609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin-loaded redox-responsive mesoporous silica nanoparticles for targeted breast cancer therapy.
    Li N; Wang Z; Zhang Y; Zhang K; Xie J; Liu Y; Li W; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):921-935. PubMed ID: 29790797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
    Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
    ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-miRNA21 and resveratrol-loaded polysaccharide-based mesoporous silica nanoparticle for synergistic activity in gastric carcinoma.
    Hu Y; Wang Z; Qiu Y; Liu Y; Ding M; Zhang Y
    J Drug Target; 2019 Dec; 27(10):1135-1143. PubMed ID: 31017473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe
    Fang Z; Li X; Xu Z; Du F; Wang W; Shi R; Gao D
    Int J Nanomedicine; 2019; 14():5785-5797. PubMed ID: 31440047
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
    Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E
    ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic Acid-Functionalized Mesoporous Silica Nanoparticles Loading Simvastatin for Targeted Therapy of Atherosclerosis.
    Song K; Tang Z; Song Z; Meng S; Yang X; Guo H; Zhu Y; Wang X
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.